DJIA53577.40 160.24
S&P 5007677.28 24.42
NASDAQ26151.30 171.11
Russell 20003013.00 8.90
German DAX26266.14 159.54
FTSE 10010886.16 31.84
CAC 408439.20 -13.81
EuroStoxx 506457.75 8.60
Nikkei 22565856.43 328.34
Hang Seng25511.10 -6.23
Shanghai Comp3889.44 7.43
KOSPI6742.74 45.78
Bloomberg Comm IDX138.23 -1.15
WTI Crude-fut84.01 -4.13
Brent Crude-fut80.99 -4.09
Natural Gas2.85 0.04
Gasoline-fut2.89 -0.08
Gold-fut4728.30 9.80
Silver-fut69.00 -0.17
Platinum-fut1872.00 -25.90
Palladium-fut1342.00 -21.00
Copper-fut680.95 9.95
Aluminum-spot3195.00 0.00
Coffee-fut335.50 -6.15
Soybeans-fut1237.75 13.50
Wheat-fut703.25 3.75
Bitcoin78886.72 167.23
Ethereum USD2454.55 -20.62
Litecoin49.70 -1.74
Dogecoin0.09 0.00
EUR/USD1.1668 0.0004
USD/JPY159.28 0.09
GBP/USD1.3639 0.0007
USD/CHF0.8027 -0.0005
USD IDX98.92 -0.08
US 10-Yr TR4.639 0
GER 10-Yr TR3.1801 -0.024
UK 10-Yr TR4.9838 -0.0077
JAP 10-Yr TR2.881 -0.011
Fed Funds3.75 0
SOFR3.65 0
High-rise commercial buildings

Sub Markets

Topics

Alternative Assets  + Private Equity  | 
Carlyle-owned Life Sciences Firm Abingworth Names Joy Gosh as Managing Director

Carlyle-owned Life Sciences Firm Abingworth Names Joy Gosh as Managing Director

Abingworth, the Carlyle-owned international life sciences investment group with approximately $2bn under management, has recently appointed Joy Ghosh, PhD as managing director.

Ghosh will be based in Boston and work with the team to identify new investment opportunities and support existing investments in private and public companies, including those focused on clinical co-development.

Ghosh has over 15 years’ experience in life science investing and portfolio management, and in corporate strategy and drug development.

Gosh previously worked at Eventide Asset Management as a portfolio manager responsible for a portfolio of innovation-focused public and private healthcare and life science companies.

Prior to Eventide, Ghosh was vice president at Bain Capital. He has completed 24 private investments during his time at both firms and was on the board of multiple companies.

Earlier in his career, Ghosh held senior roles in business development and corporate strategy at Biogen, and as a project team leader at Novartis Institutes for BioMedical Research (NIBR).

Connect

Inside The Story

Abingworth

About Joe Palmisano

Joe Palmisano is Editorial Director for Connect Money, where he brings nearly three decades experience of market insights as a financial journalist, analyst and senior portfolio manager for leading financial publications, advisory firms, and hedge funds. In his role as Editorial Director, Joe is responsible for the selection of content and creation of daily business news covering the financial markets, including Alternative Assets, Direct Investment and Financial Advisory services. Before joining Connect Money, Joe was a financial journalist for the Wall Street Journal, regularly publishing feature stories and trend pieces on the foreign exchange, global fixed income and equity markets. Joe parlayed his experience as a financial journalist into roles as a Senior Research Analyst and Portfolio Manager, writing daily and weekly market analysis and managing a FX and US equity portfolio. Joe was also a contributing writer for industry magazines and publications, including SFO Magazine and the CMT Association. Joe earned a B.S.B.A. in Finance from The American University. He holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.

New call-to-action
New call-to-action